Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age ≥60”

441 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 441 results

Not applicableStudy completedNCT06204224
What this trial is testing

Personal Variables Affecting the Successful Aging

Who this might be right for
AgingHealthy LifestyleCoping Skills
Marmara University Pendik Training and Research Hospital 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06294262
What this trial is testing

Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine

Who this might be right for
Vaccination Reaction
LiteVax BV 84
Large-scale testing (Phase 3)Study completedNCT04886596
What this trial is testing

Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 26,675
Post-approval studies (Phase 4)Study completedNCT01591837
What this trial is testing

Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy Volunteers

Who this might be right for
Influenza, Human
Seqirus 120
Large-scale testing (Phase 3)Ended earlyNCT05242432
What this trial is testing

Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Pharmaceutical K.K. 2,192
Early research (Phase 1)Study completedNCT04568811
What this trial is testing

The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine

Who this might be right for
Adenovirus Type-5 Vectored COVID-19 Vaccine
Jiangsu Province Centers for Disease Control and Prevention 89
Testing effectiveness (Phase 2)Study completedNCT00788892
What this trial is testing

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Jazz Pharmaceuticals 126
Not applicableActive Not RecruitingNCT06546800
What this trial is testing

SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER

Who this might be right for
Respiratory Syncytial Virus Infection
Pfizer 1,100
Not applicableUnknownNCT05359107
What this trial is testing

The "Free From Pain Exercise Book" Versus "The Back Book".

Who this might be right for
SarcopeniaBack PainArthritis
Talita Cumi Ltd. 60
Not applicableActive Not RecruitingNCT06444828
What this trial is testing

Comparing Outcomes of Non-surgical Versus Surgical Treatment of Shoulder Fractures With Different Shoulder Replacements

Who this might be right for
Proximal Humeral FractureHumeral Head Fracture
University of Southern Denmark 90
Testing effectiveness (Phase 2)Study completedNCT00363077
What this trial is testing

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

Who this might be right for
Influenza
GlaxoSmithKline 150
Large-scale testing (Phase 3)Study completedNCT06060067
What this trial is testing

Dengue Vaccine in Healthy Children, Teenagers and Adults in India

Who this might be right for
Healthy Volunteers
Takeda 480
Large-scale testing (Phase 3)Study completedNCT01478542
What this trial is testing

OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

Who this might be right for
CD20+ Aggressive B-Cell Lymphoma
Universität des Saarlandes 1,152
Large-scale testing (Phase 3)Study completedNCT00860639
What this trial is testing

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Who this might be right for
Acute Myeloid Leukemia
Nantes University Hospital 327
Not applicableNot Yet RecruitingNCT07342023
What this trial is testing

Contribution of GFAP and UCH-L1 Assays in Whole Blood to Optimizing Personalized Care for "Repeated Fallers" Hospitalized in Geriatric Wards

Who this might be right for
Fallers Aged 60 Years and OlderBiomarkers / BloodIntracranial Bleeding
University Hospital, Clermont-Ferrand 770
Testing effectiveness (Phase 2)Looking for participantsNCT06679829
What this trial is testing

Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 215
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Post-approval studies (Phase 4)Study completedNCT01863433
What this trial is testing

Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

Who this might be right for
Influenza, Human
Seqirus 120
Not applicableStudy completedNCT04188678
What this trial is testing

Resiliency in Older Adults Undergoing Bone Marrow Transplant

Who this might be right for
LeukemiaLymphomaBlood Cancer+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 126
Load More Results